IRCT20200111046082N1已完成未知
The Efficacy assessment of high definition cathodal transcranial direct current stimulation in treatment of patients with drug-resistant epilepsy
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age>=18 y/o
- •all of patients full filled ILAE criteria of drug-resistant epilepsy
- •participants were not good candidate for epilepsy surgery and or they will not surgery or they waited for epilepsy surgery.
- •obtaining signed consent
排除标准
- •scalp diseases(such as eczema, skin lesions)
- •previous intracranial surgery, intracranial metal (out of mouth) such as cracking, surgical clip
- •implanted device such as cardiac pacemaker, VNS, Cochlear implantation
- •recurrent or severe headaches
- •previous head trauma and other related brain diseases
- •pregnancy and lactation
研究者
相似试验
已完成
不适用
Investigation of the efficacy and safety of high-dose clarithromycin in adult patients with community-acquired pneumonia-multicenter,single-group,open-label studyAdult community-acquired pneumoniaJPRN-UMIN000016277Department of medicine, Division of clinical infectious diseases, School of medicine, Showa university30
尚未招募
1 期
Evaluation of the effects of the Good Cholesterol on Wound HealingImpaired wound healingSkin - Other skin conditionsMetabolic and Endocrine - DiabetesDiabetic Foot UlcerACTRN12619000269134niversity of Adelaide142
招募中
3 期
The effect of high-intensity laser therapy on knee osteoarthritisknee osteoarthritis.Osteoarthritis of kneeIRCT20220214054022N1Esfahan University of Medical Sciences50
进行中（未招募）
4 期
A Study of Efficacy and Safety of High-Intensity Focused Ultrasound for the Treatment of Melasma in Asians: A Single-Blind, Randomized, Split-face Pilot StudyMelasma on both sides of the facechlorasmamelasmamask of pregnancyHIFUHIFTCTR20180424005Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital25
已完成
2 期
Clinical efficacy and safety assessment of high-dose Bevacizumab plus Fluorouracil and Leucovorin (sLV5FU2) in patients with standard chemotherapy refractory metastatic colorectal cancer. phase II multicenter trial.Metastatic colorectal cancer patients who have been either refractory to or intolerant of prior all approved standard chemotherapy.JPRN-UMIN000009802The University of Tokyo, Graduate School of Medicine. Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery25